Kyowa Hakko Kirin Accelerates Antibody Clinical Studies In Japan
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin commenced a domestic clinical trial for monoclonal antibody drug BIW-8405 for patients with asthma